Source: Nasdaq

Eli Lilly: ANALYSIS-Alzheimer's drug trial breakthrough boost for Roche, Eli Lilly

The results of a key Alzheimer's drug trial on Wednesday have reignited decades-old hopes that targeting a particular protein helps arrest the progression of the fatal brain disease, giving a big boost to similar studies being run by Roche and Eli Lilly.

Read full article »
Annual Revenue
David A. Ricks's photo - Chairman & CEO of Lilly

Chairman & CEO

David A. Ricks

CEO Approval Rating


Read more